State Key Laboratory of Cardiovascular Disease Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Cardiomyopathy Ward Fuwai Hospital National Center for Cardiovascular Disease Chinese Academy of Medical Science and Peking Union Medical College Beijing China.
J Am Heart Assoc. 2021 Feb;10(5):e018236. doi: 10.1161/JAHA.120.018236. Epub 2021 Feb 15.
Background The (formin homology 2 domain-containing 3) gene has recently been identified as a causative gene of hypertrophic cardiomyopathy (HCM). However, the pathogenicity of variants remains to be evaluated. This study analyzed the spectrum of variants in a large HCM and control cohort, and explored its correlation with the disease. Methods and Results The genetic analysis of was performed using the whole exome sequencing data from 1000 patients with HCM and 761 controls without HCM. A total of 37 candidate variants were identified, including 25 missense variants and 2 truncating variants. In detail, there were 27 candidate variants detected in 33 (3.3%) patients with HCM, which was significantly higher than in the 12 controls (3.3% versus 1.6%; odds ratio, 2.13; <0.05). On the basis of familial segregation, we identified one truncating variant (c.1286+2delT) as a causal variant in 4 patients. Furthermore, the candidate variant experienced significantly more risk of cardiovascular death and all-cause death (adjusted hazard ratio [HR], 3.71; 95%, 1.32-8.59; =0.016; and adjusted HR, 3.02; 95% CI, 1.09-6.85; 0.035, respectively). Conclusions Our study suggests that is a causal gene for HCM, and that the presence of candidate variants is an independent risk for cardiovascular death and all-cause death in HCM.
背景 肌球蛋白结合蛋白 C 基因(myosin binding protein C,MYBPC3)最近被鉴定为肥厚型心肌病(hypertrophic cardiomyopathy,HCM)的致病基因。然而,其变异的致病性仍需评估。本研究分析了一个大型 HCM 及对照队列中 MYBPC3 变异的谱,并探讨了其与疾病的相关性。
方法和结果 采用 1000 例 HCM 患者和 761 例无 HCM 对照者的外显子组测序数据进行 MYBPC3 基因的遗传分析。共发现 37 个候选变异,包括 25 个错义变异和 2 个截断变异。详细地,在 33 例(3.3%)HCM 患者中检测到 27 个候选变异,明显高于 12 例对照者(3.3%比 1.6%;比值比,2.13;<0.05)。基于家族分离,我们在 4 例患者中发现了一个截断变异(c.1286+2delT)为致病变异。此外,候选变异明显增加了心血管死亡和全因死亡的风险(校正后的危险比[HR],3.71;95%可信区间,1.32-8.59;=0.016;和校正后的 HR,3.02;95%可信区间,1.09-6.85;=0.035)。
结论 本研究提示 MYBPC3 是 HCM 的致病基因,候选变异的存在是 HCM 患者心血管死亡和全因死亡的独立危险因素。